These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 436528

  • 1. Precipitation of heart failure following sudden withdrawal of hydralazine.
    Black JR, Mehta J.
    Chest; 1979 Jun; 75(6):724-5. PubMed ID: 436528
    [Abstract] [Full Text] [Related]

  • 2. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL, Cohn JN, Franciosa JA.
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract] [Full Text] [Related]

  • 3. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
    Ribner HS, Zucker MJ, Stasior C, Talentowski D, Stadnicki R, Lesch M.
    Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
    [Abstract] [Full Text] [Related]

  • 4. Combined therapy with digoxin and nitroprusside in heart failure complicating acute myocardial infarction.
    Raabe DS.
    Am J Cardiol; 1979 May; 43(5):990-4. PubMed ID: 433783
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
    Franciosa JA, Pierpont G, Cohn JN.
    Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Usefulness of vasodilator therapy in acute and chronic valvular regurgitation.
    Greenberg BH, Rahimtoola SH.
    Curr Probl Cardiol; 1984 Jul; 9(4):1-46. PubMed ID: 6744937
    [No Abstract] [Full Text] [Related]

  • 9. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
    Cogan JJ, Humphreys MH, Carlson CJ, Benowitz NL, Rapaport E.
    Circulation; 1981 Nov; 64(5):973-6. PubMed ID: 7285311
    [Abstract] [Full Text] [Related]

  • 10. Specific afterload reduction with parenteral hydralazine following cardiac surgery.
    Sladen RN, Rosenthal MH.
    J Thorac Cardiovasc Surg; 1979 Aug; 78(2):195-202. PubMed ID: 459526
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
    Packer M, Meller J, Medina N, Yushak M, Gorlin R.
    N Engl J Med; 1982 Jan 14; 306(2):57-62. PubMed ID: 7053487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
    Greenberg BH, Massie BM.
    Circulation; 1980 Jun 14; 61(6):1212-6. PubMed ID: 7371134
    [No Abstract] [Full Text] [Related]

  • 18. Hydralazine in the management of left ventricular failure.
    Fitchett DH, Neto JA, Oakley CM, Goodwin JF.
    Am J Cardiol; 1979 Aug 14; 44(2):303-9. PubMed ID: 463768
    [No Abstract] [Full Text] [Related]

  • 19. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV.
    Ann Intern Med; 1981 Jul 14; 95(1):5-13. PubMed ID: 7247126
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.